Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cancer, Carcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)WithdrawnNCT01179269
What this trial is testing

Pazopanib and Paclitaxel for Non-Small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
Loyola University
Large-scale testing (Phase 3)Looking for participantsNCT07383441
What this trial is testing

Adding Biotherapy or Placebo to Standard Treatment for Advanced Kidney Cancer

Who this might be right for
Advanced Clear Cell Renal Cell CarcinomaMetastatic Clear Cell Renal Cell CarcinomaStage III Renal Cell Cancer AJCC v8+1 more
SWOG Cancer Research Network 718
Testing effectiveness (Phase 2)Looking for participantsNCT07340541
What this trial is testing

Evolutionary Clinical Trial for Novel Biomarker-Driven Therapies

Who this might be right for
Breast CancerMetastatic Breast CancerTriple Negative Breast Cancer+2 more
UNC Lineberger Comprehensive Cancer Center 700
Testing effectiveness (Phase 2)Ended earlyNCT00664105
What this trial is testing

Ph II Concurrent Chemo t/Docetaxel/Carboplatin/Radio Therapy-consolidation t/Locally Adv Inoperable Non-Small Cell Lung Cancer (NSCLC)

Who this might be right for
Lung Cancer
Vanderbilt-Ingram Cancer Center 63
Testing effectiveness (Phase 2)Study completedNCT00096447
What this trial is testing

Lapatinib in Treating Patients With Recurrent or Persistent Endometrial Cancer

Who this might be right for
Recurrent Endometrial Carcinoma
National Cancer Institute (NCI) 31
Testing effectiveness (Phase 2)Ended earlyNCT01806649
What this trial is testing

BKM120 in Esophageal Squamous Cell Carcinoma After Failure of First Line Chemotherapy

Who this might be right for
Esophageal Cancer
Prince of Songkla University 5
Very early researchStudy completedNCT02467738
What this trial is testing

Surgical Resection and Intraoperative Cesium-131 Brachytherapy for Head and Neck Cancer

Who this might be right for
Recurrent Head and Neck Carcinoma
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 30
Not applicableStudy completedNCT00321048
What this trial is testing

Spect Analysis of Cardiac Perfusion Changes After Whole Breast/Chest Wall Radiation Therapy With ABC

Who this might be right for
Breast NeoplasmsCarcinoma, DuctalAdenocarcinoma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 57
Testing effectiveness (Phase 2)Study completedNCT01514526
What this trial is testing

Clinical Trial of Dovitinib in First-line Metastatic or Locally Advanced Non-resectable Adrenocortical Carcinoma

Who this might be right for
Adrenocortical Carcinoma
Spanish Oncology Genito-Urinary Group 17
Not applicableStudy completedNCT06463626
What this trial is testing

Real-life Treatment Patterns With Cyclin-dependent Kinase Inhibitors in Advanced Breast Cancer in Portugal - REVEAL Study

Who this might be right for
Hormone-receptor-positive Breast CancerHuman Epidermal Growth Factor 2 Negative Carcinoma of Breast
Novartis 121
Early research (Phase 1)Looking for participantsNCT06582017
What this trial is testing

Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma

Who this might be right for
Ovarian CancerPancreas CancerUrothelial Carcinoma+6 more
Nammi Therapeutics Inc 100
Early research (Phase 1)Study completedNCT01519817
What this trial is testing

Cancer Vaccine Targeting Brachyury Protein in Tumors

Who this might be right for
NeoplasmsMalignant Solid TumorsColon Neoplasms+1 more
National Cancer Institute (NCI) 34
Not applicableStudy completedNCT03222440
What this trial is testing

Combination of Radiotherapy and SHR-1210 to Treat Patients With ESCC

Who this might be right for
Esophageal Cancer
Tianjin Medical University Cancer Institute and Hospital 20
Testing effectiveness (Phase 2)UnknownNCT00663689
What this trial is testing

Efficacy of Erlotinib for Brain Metastasis of Non-Small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung CancerBrain Metastases
Guangdong Provincial People's Hospital 45
Not applicableStudy completedNCT01028638
What this trial is testing

Vascular Endothelial Growth Factor (VEGF) Imaging Before and During Everolimus Treatment for Renal Cell Carcinoma

Who this might be right for
Metastatic Renal Cell Carcinoma
University Medical Center Groningen 13
Not applicableStudy completedNCT02315755
What this trial is testing

Observational Study Evaluating The Efficacy And Effects On Quality Of Life Of Targeted Treatments Following TKIs In mRCC

Who this might be right for
Renal Cell Carcinoma
Pfizer 102
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07049185
What this trial is testing

QL1706 Plus Celecoxib in Advanced Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Squamous Cell Carcinoma
Peking University Cancer Hospital & Institute 35
Not applicableUnknownNCT05376943
What this trial is testing

Possible Differences in HCC Course Depending on DAA Treatment

Who this might be right for
Carcinoma, HepatocellularHepatitis C Virus Infection, Response to Therapy ofDrug Effect+3 more
Medical University of Warsaw 100
Testing effectiveness (Phase 2)Study completedNCT01580735
What this trial is testing

ARQ 197 Plus Erlotinib in Patient With Locally Advanced or Metastatic EGFR Mutation-positive Non-small-cell Lung Cancer

Who this might be right for
Non-small-cell Lung Cancer
Kyowa Kirin Co., Ltd. 40
Not applicableEnded earlyNCT01799135
What this trial is testing

Feasibility Study of Enhanced MRI for Early Stage Non Small Cell Lung Cancer (NSCLC)

Who this might be right for
Non Small Cell Lung Cancer
Dana-Farber Cancer Institute 6
Next Page